Related Experiment Video
Updated: Jun 6, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Guinea pig ileum motility stimulation elicited by N-formyl-Met-Leu-Phe (fMLF) involves neurotransmitters and
Mariantonella Colucci1, Marica Mastriota, Francesco Maione
1Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, viale Regina Elena 299, 00161 Rome, Italy.
Abstract:
In guinea-pig ileum (GPI), the chemotactic peptide N-formyl-Met-Leu-Phe-OH (fMLF) possesses spasmogenic properties through the activation of formyl peptide receptors (FPRs). Despite this, the mediators involved remain to be elucidated. fMLF (1nM-1μM) induced a dose-dependent contraction of GPI (EC(50)=24nM), that is blocked by pre-treatment with the FPRs antagonist Boc(2). The pre-treatment with tetrodotoxin (TTX) atropine or with SR140333 reduced the fMLF-induced contraction, whereas with hexamethonium, MEN10627, SB222200, mepyramine, cimetidine, thioperamide or methysergide did not produce any effect. With DuP697 pre-treatment, but not with piroxicam, reduced the fMLF-induced contraction. After stimulation with 24nM fMLF, a strong increase in the PGE(2) levels was observed. Finally, the concomitant blocking of the NK(1) receptor, the muscarinic receptors and COX-2 abolished the GPI contractions induced by fMLF. fMLF induced a concentration-dependent contraction of guinea-pig jejunum (EC(50)=11nM), proximal colon (EC(50)=3.5nM) and distal colon (EC(50)=2.2nM), with a time-course similar to that observed in GPI. In these preparations as well, the co-administration of atropine, SR140333 and DuP697 abolished the contractions induced by fMLF. Intraperitoneal injection of fMLF (0.1 or 1μmol/kg) enhanced the gastrointestinal motility in mice, abolished by the co-administration of atropine, SR140333 and DuP697. In conclusion, we showed that fMLF exerts spasmogenic actions on guinea-pig intestine both in vitro and in vivo through the release of acetylcholine and substance P from myenteric motorneurons and through prostanoids, probably from the inflammatory cells of the enteric immune system.
Insights
The chemotactic peptide N-formyl-Met-Leu-Phe-OH (fMLF) causes intestinal contractions by activating formyl peptide receptors (FPRs). This spasmogenic effect involves acetylcholine, substance P, and prostanoids, impacting gastrointestinal motility.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- The chemotactic peptide N-formyl-Met-Leu-Phe-OH (fMLF) activates formyl peptide receptors (FPRs) and exhibits spasmogenic properties in the guinea-pig ileum (GPI).
- The precise mediators underlying fMLF-induced gastrointestinal contractions remain incompletely understood.
Purpose of the Study:
- To elucidate the signaling pathways and mediators involved in fMLF-induced spasmogenic effects on guinea-pig gastrointestinal tissues.
- To investigate the in vivo effects of fMLF on gastrointestinal motility in mice.
Main Methods:
- Dose-dependent contractions of GPI, jejunum, and colon induced by fMLF were measured in vitro.
- The effects of various receptor antagonists (Boc(2), TTX, atropine, SR140333, DuP697, etc.) and COX-2 inhibition were assessed.
- PGE(2) levels were measured post-fMLF stimulation.
- In vivo gastrointestinal motility in mice was evaluated following fMLF administration.
Main Results:
- fMLF induced dose-dependent contractions in GPI, jejunum, and colon.
- Contractions were significantly reduced by antagonists of FPRs, muscarinic receptors (atropine), NK(1) receptors (SR140333), and COX-2 (DuP697).
- fMLF stimulation led to increased PGE(2) levels.
- fMLF enhanced gastrointestinal motility in mice.
Conclusions:
- fMLF exerts spasmogenic actions on the guinea-pig intestine via FPR activation.
- These effects are mediated by the release of acetylcholine and substance P from myenteric motor neurons.
- Prostanoids, likely from inflammatory cells, also contribute to fMLF-induced contractions, impacting both in vitro and in vivo gastrointestinal motility.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Feces Formation and Defecation
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...

